Europe · Wires & real time · Reuters Technology
Danaher says it has 'building blocks' for AI drug discovery growth
Life sciences firm Danaher is well positioned to benefit as drugmakers increasingly adopt artificial intelligence to develop new medicines, its chief executive said on Wednesday,…
Read the full article on Reuters Technology Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)
